Publications | ReTune

Converging metabolic and functional networks for tremor expression and deep brain stimulation-mediated control.

Weigl et al. 2026 NPJ Parkinsons Dis.

Here, we used [18F]-fluorodeoxyglucose (FDG)-PET in 14 essential tremor patients undergoing thalamic deep brain stimulation (DBS) to identify stimulation-induced and tremor related regional metabolic changes in a within-subject design and combined this with normative connectome results.

Published:

Region-based morphometry in Parkinson’s Disease patients with GBA mutation and its predictive role for cognition after STN-DBS.

Reimer et al. 2026 Parkinsonism Relat Disord.

We applied region-based morphometry (RBM) using the CAT12-toolbox to identify baseline atrophy patterns in GBA + PD patients undergoing evaluation for STN-DBS.

The chronical outcome monitoring in dystonia with deep brain stimulation (COMEDD) study protocol: a longitudinal evaluation of chronic electrophysiological biomarkers in patients with dystonia and deep brain stimulation therapy.

Feldmann et al. 2026 Dystonia.

We here present a feasible, systematic protocol for identification of electrophysiological biomarkers in dystonia to establish electrophysiology-based guidance of therapy optimization in dystonia.

Identifying maximal beta power from directional subthalamic local field potentials in Parkinson’s disease.

Behnke et al. 2026 NPJ Parkinsons Dis.

In 39 patients, we validated three methods to estimate pseudo-monopolar beta power.

DBSsync: combining intracranial and multimodal data to investigate new biomarkers in Parkinson’s disease.

Vivien et al. 2026 NPJ Parkinsons Dis.

We developed DBSsync, a paradigm and an open-source Python toolbox with its graphical user interface for temporally precise synchronization of intracranial recordings with external data, allowing for multimodal research protocols.

Varying patterns of association between cortical large-scale networks and subthalamic nucleus activity in Parkinson’s disease.

Kohl et al. 2026 NPJ Parkinsons Dis.

We analysed simultaneous magnetoencephalography and subthalamic nucleus (STN) local field potential recordings from 27 individuals with Parkinson’s disease, both on and off dopaminergic medication.